Link to Published Abstract

Poster is available to registered attendees only via the ASH annual meeting virtual platform, as per congress regulations. 

Session Title: Session - Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Poster Board: 368

Session Date and Time: Monday, 1 June, 2026; 9:00 AM-12:00 PM CDT   

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib following a switch from ruxolitinib: The MY-PAC Study

Douglas Tremblay, Abiola Oladapo, Michael Marrone, Puja Aggarwal, Caleb Paydar, Djibril Liassou, Purvi Suthar, Adina Geprifti, Michael Vredenburg , Bruce Feinberg, James Rossetti, Naveen Pemmaraju

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Incidence, prevalence, and clinical outcomes of myelofibrosis with and without cytopenia in the United States

Aaron T Gerds, Lindsay AM Rein, Nicole M Engel-Nitz, Michael Marrone, Jeffrey McPheeters, Abiola Oladapo, Purvi Suthar, Michael Vredenburg , Yong Zhu, Lucia Masarova

Publication
  • ASH •
  • 7 December, 2025 •
  • •

Real-world treatment patterns and outcomes in patients with myelofibrosis who presented with thrombocytopenia and anemia at initiation of pacritinib treatment

Naveen Pemmaraju, Abiola Oladapo, Michael Marrone, Puja Aggarwal, Caleb Paydar, Djibril Liassou, Purvi Suthar, Adina Geprifti, Michael Vredenburg , Bruce Feinberg, James Rossetti, Douglas Tremblay

Publication
  • ASH •
  • 7 December, 2025 •
  • •

Real-World Treatment Patterns and Clinical Outcomes in Patients with Myelofibrosis Treated with Pacritinib (PAC): Results from the MY-PAC Study

Douglas Tremblay, Abiola Oladapo, Michael Marrone, Puja Aggarwal, Caleb Paydar, Djibril Liassou, Purvi Suthar, Adina Geprifti, Gerard Hoehn, Michael Vredenburg , Bruce Feinberg, Naveen Pemmaraju, James Rossetti

Sign up for alerts